Forsythiaside A Alleviates Kidney Injury and Intestinal Epithelium Dysfunction in IgA Nephropathy by Inhibiting TLR4 / NF ‐ κB Signaling
The Kaohsiung Journal of Medical Sciences · 2026
DOI: 10.1002/kjm2.70144 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2026. Verfasst von Meng-Si Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, China Resources & WISCO General Hospital, Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, Glomerulonephritis, IGA, Glycosides, Intestinal Mucosa. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
IgA nephropathy (IgAN), the most common form of glomerulonephritis, is a major and growing public health issue. It results from intestinal barrier dysfunction that leads to mesangial deposition of pathogenic galactose‐deficient IgA1 (Gd‐IgA1) and renal inflammation. This study aimed to investigate the therapeutic effects and associated mechanisms of forsythiaside A on intestinal barrier injury in IgAN in animal models. Rats were treated with bovine serum albumin (BSA), carbon tetrachloride (CCl 4 ), and lipopolysaccharide (LPS) to induce IgAN, followed by intragastric administration of forsythiaside A once daily from weeks 15 to 20 after model establishment. Biochemical markers, including 24‐h urinary protein, blood urea nitrogen (BUN), serum creatinine (SCr), renal and intestinal tissue pathology, and levels of pro‐inflammatory cytokines in the serum, kidney, and intestine, intestinal tight junction proteins, and TLR4/NF‐κB pathway components were examined. The results showed that forsythiaside A decreased 24‐h urinary protein, BUN, and SCr levels, alleviated renal damage, and attenuated glomerular and tubular lesions, collagen deposition, and glomerular IgA deposition in IgAN rats. Forsythiaside A treatment inhibited CD68‐positive macrophage infiltration in renal tissues and downregulated serum and renal levels of IL‐1β, IL‐6, and TNF‐α, while also alleviating intestinal barrier injury and intestinal inflammation, as shown by reduced levels of IL‐1β, IL‐6, and TNF‐α and increased expression of the intestinal tight junction proteins occludin and ZO‐1. Lastly, forsythiaside A treatment lowered serum LPS concentrations, as well as renal and intestinal levels of TLR4, p‐NF‐κB p65, and p‐IκBα, and raised both renal and intestinal levels of IκBα. Collectively, forsythiaside A was found to ameliorate the progression of IgAN in rats by alleviating inflammation and intestinal barrier injury by suppression of TLR4/NF‐κB signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, China Resources & WISCO General Hospital, Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China.
ORCID-Profile: Kai Liu
Zitieren
APA
Li, M. S., & Liu, K. (2026). Forsythiaside A Alleviates Kidney Injury and Intestinal Epithelium Dysfunction in IgA Nephropathy by Inhibiting TLR4 / NF ‐ κB Signaling. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.70144
Vancouver
Li MS, Liu K. Forsythiaside A Alleviates Kidney Injury and Intestinal Epithelium Dysfunction in IgA Nephropathy by Inhibiting TLR4 / NF ‐ κB Signaling. The Kaohsiung Journal of Medical Sciences. 2026. doi:10.1002/kjm2.70144
BibTeX
@article{Li2026,
author = {Li, Meng-Si and Liu, Kai},
title = {Forsythiaside A Alleviates Kidney Injury and Intestinal Epithelium Dysfunction in IgA Nephropathy by Inhibiting TLR4 / NF ‐ κB Signaling},
journal = {The Kaohsiung Journal of Medical Sciences},
year = {2026},
doi = {10.1002/kjm2.70144}
}
EUVIMED